Co-Diagnostics (CODX) vs Sonoma Pharmaceuticals (SNOA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Co-Diagnostics is the larger company by market cap ($7.6 million vs $5.6 million), about 1.4 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CODX | SNOA |
|---|---|---|
| Share price | $1.09 | $1.16 |
| Market cap | $7.61M | $5.55M |
| 1-day change | -2.68% | -4.92% |
| EPS (TTM) | $-26.14 | $-1.22 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $46.50 | $4.30 |
| 52-week low | $0.906 | $0.85 |
| Distance from 52-week high | -97.66% | -73.02% |
| Analyst consensus | none | — |
| Avg. price target upside | +266.97% | — |
| Average volume | 326.57K | 107.65K |
| Shares outstanding | 6.98M | 4.79M |
| Employees | 115 | 10 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Co-Diagnostics
CODX stock →Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally.
Health Care · Medical/Dental Instruments · 115 employees
About Sonoma Pharmaceuticals
SNOA stock →Sonoma Pharmaceuticals, Inc. develops and produces stabilized hypochlorous acid (HOCl) products for wound and eye care, oral and nasal care, podiatry, animal health care, and dermatological conditions in the United States, Europe, Asia, Latin America, and internationally.
Health Care · Medical/Dental Instruments · 10 employees
CODX vs SNOA FAQ
Which is bigger, Co-Diagnostics or Sonoma Pharmaceuticals?
Co-Diagnostics (CODX) is larger, with a market capitalization of $7.61M compared with $5.55M for Sonoma Pharmaceuticals (SNOA).
Are Co-Diagnostics and Sonoma Pharmaceuticals in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.